Norgestimate/Ethinyl Estradiol Tablets SPE2D2-25-D-0009
Summary
AI-generated · Mar 27, 2026Option Year 1 is being exercised to extend the contract for Norgestimate/Ethinyl Estradiol Tablets for a one-year period. The award is to AVKARE LLC for a total value of $4,229,263.40.
SPE2D2-25-D-0009 P00001 to exercise Option Year 1 effective April 27, 2026 through April 26, 2027. SPE2D2-25-D-0009 Norgestimate/Ethinyl Estradiol Tablets Award
From Award Notice posted on Mar 26, 2026Notice history
1-
Award Notice LATEST Posted Mar 26, 2026
Details
Award Information
Award Notices
Posted: Mar 26, 2026
SPE2D2-25-D-0009 P00001 to exercise Option Year 1 effective April 27, 2026 through April 26, 2027. SPE2D2-25-D-0009 Norgestimate/Ethinyl Estradiol Tablets Award
Awardees
| Company Name | UEI | CAGE Code | Location |
|---|---|---|---|
| AVKARE LLC | SFPGXE6XPS93 | 4QGW8 | Pulaski, TN |
Contacts
Phone
Phone
Agency
Place of Performance
ESP